Skin sensitizers induce antioxidant response element dependent genes: application to the in vitro testing of the sensitization potential of chemicals.

Tests for skin sensitization are required prior to the market launch of new cosmetic ingredients and in vitro tests are needed to replace the current animal tests. Protein reactivity is the common feature of skin sensitizers and it is a crucial question whether a cellular in vitro assay can detect protein reactivity of diverse test chemicals. The signaling pathway involving the repressor protein Keap1 and the transcription factor nuclear factor-erythroid 2-related factor 2, which binds to the antioxidant response element (ARE) in the promoter of many phase II detoxification genes, is a potential cellular marker because Keap1 had been shown to be covalently modified by electrophiles which leads to activation of ARE-dependent genes. To evaluate whether this regulatory pathway can be used to develop a predictive cellular in vitro test for sensitization, 96 different chemicals of known skin sensitization potential were added to Hepa1C1C7 cells and the induction of the ARE-regulated quinone reductase (QR) activity was determined. In parallel, 102 chemicals were tested on the reporter cell line AREc32, which contains an eightfold repeat of the ARE sequence upstream of a luciferase gene. Among the strong/extreme skin sensitizers 14 out of 15 and 30 out of 34 moderate sensitizers induced the ARE-dependent luciferase activity and in many cases this response was paralleled by an induction of QR activity in Hepa1C1C7 cells. Sixty percent of the weak sensitizers also induced luciferase activity, and the overall accuracy of the assay was 83 percent. Only four of 30 tested nonsensitizers induced low levels of luciferase activity, indicating a high specificity of the assay. Thus, measurement of the induction of this signaling pathway provides an interesting in vitro test to screen for the skin sensitization potential of novel chemicals.

[1]  M. O'Connell,et al.  Role of protein kinase C delta in curcumin-induced antioxidant response element-mediated gene expression in human monocytes. , 2006, Biochemical and biophysical research communications.

[2]  G Frank Gerberick,et al.  Identification of gene expression changes induced by chemical allergens in dendritic cells: opportunities for skin sensitization testing. , 2006, The Journal of investigative dermatology.

[3]  Grace Patlewicz,et al.  Mechanistic applicability domains for non-animal based prediction of toxicological endpoints. QSAR analysis of the schiff base applicability domain for skin sensitization. , 2006, Chemical research in toxicology.

[4]  J. Pezzuto,et al.  Induction of quinone reductase as a primary screen for natural product anticarcinogens. , 2004, Methods in enzymology.

[5]  G Frank Gerberick,et al.  Local lymph node assay (LLNA) for detection of sensitization capacity of chemicals. , 2007, Methods.

[6]  G Frank Gerberick,et al.  Development of a peptide reactivity assay for screening contact allergens. , 2004, Toxicological sciences : an official journal of the Society of Toxicology.

[7]  M. Pallardy,et al.  Implication of the MAPK pathways in the maturation of human dendritic cells induced by nickel and TNF-alpha. , 2005, Toxicology.

[8]  Ken Itoh,et al.  Modulation of Gene Expression by Cancer Chemopreventive Dithiolethiones through the Keap1-Nrf2 Pathway , 2003, The Journal of Biological Chemistry.

[9]  Paul Talalay,et al.  Protection against electrophile and oxidant stress by induction of the phase 2 response: Fate of cysteines of the Keap1 sensor modified by inducers , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[10]  G Frank Gerberick,et al.  Gene expression changes in peripheral blood-derived dendritic cells following exposure to a contact allergen. , 2004, Toxicology letters.

[11]  R J Fielder,et al.  Local lymph node assay - validation, conduct and use in practice. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[12]  I Kimber,et al.  Classification of contact allergens according to potency: proposals. , 2003, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[13]  G Frank Gerberick,et al.  Relationship of CD86 surface marker expression and cytotoxicity on dendritic cells exposed to chemical allergen. , 2005, Toxicology and applied pharmacology.

[14]  C Roland Wolf,et al.  Generation of a stable antioxidant response element-driven reporter gene cell line and its use to show redox-dependent activation of nrf2 by cancer chemotherapeutic agents. , 2006, Cancer research.

[15]  H. Sakaguchi,et al.  Development of an in vitro skin sensitization test using human cell lines; human Cell Line Activation Test (h-CLAT). II. An inter-laboratory study of the h-CLAT. , 2006, Toxicology in vitro : an international journal published in association with BIBRA.

[16]  T. Kensler,et al.  The role of Keap1 in cellular protective responses. , 2005, Chemical research in toxicology.

[17]  A. Natsch,et al.  Utility and limitations of a peptide reactivity assay to predict fragrance allergens in vitro. , 2007, Toxicology in vitro : an international journal published in association with BIBRA.

[18]  G. Yen,et al.  Effect of sulforaphane on metallothionein expression and induction of apoptosis in human hepatoma HepG2 cells. , 2005, Carcinogenesis.

[19]  Ian Kimber,et al.  Compilation of Historical Local Lymph Node Data for Evaluation of Skin Sensitization Alternative Methods , 2005, Dermatitis : contact, atopic, occupational, drug.

[20]  Carl Westmoreland,et al.  A future approach to measuring relative skin sensitising potency: a proposal , 2006, Journal of applied toxicology : JAT.

[21]  R. Saracci,et al.  Describing the validity of carcinogen screening tests. , 1979, British Journal of Cancer.

[22]  M. Pallardy,et al.  Nickel and DNCB induce CCR7 expression on human dendritic cells through different signalling pathways: role of TNF-alpha and MAPK. , 2004, The Journal of investigative dermatology.

[23]  Ian Kimber,et al.  A chemical dataset for evaluation of alternative approaches to skin‐sensitization testing , 2004, Contact dermatitis.

[24]  G. Yen,et al.  Involvement of p38 MAPK and Nrf2 in phenolic acid-induced P-form phenol sulfotransferase expression in human hepatoma HepG2 cells. , 2006, Carcinogenesis.

[25]  C. Wolf.  Chemoprevention: Increased potential to bear fruit , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[26]  B. Rovin,et al.  Activation of the Nrf2/antioxidant response pathway increases IL‐8 expression , 2005, European journal of immunology.

[27]  R. Messer,et al.  Ni(II) activates the Nrf2 signaling pathway in human monocytic cells. , 2006, Biomaterials.

[28]  G Frank Gerberick,et al.  Quantification of chemical peptide reactivity for screening contact allergens: a classification tree model approach. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[29]  John McFadden,et al.  Identification and classification of skin sensitizers: identifying false positives and false negatives , 2006, Contact dermatitis.

[30]  A. Kong,et al.  Butylated hydroxyanisole regulates ARE‐mediated gene expression via Nrf2 coupled with ERK and JNK signaling pathway in HepG2 cells , 2006, Molecular carcinogenesis.

[31]  H. Merk,et al.  A skin-like cytochrome P450 cocktail activates prohaptens to contact allergenic metabolites. , 2007, The Journal of investigative dermatology.

[32]  A. Nel,et al.  Macrophage activation by polycyclic aromatic hydrocarbons: evidence for the involvement of stress-activated protein kinases, activator protein-1, and antioxidant response elements. , 1998, Journal of immunology.

[33]  C. Goebel,et al.  Characterization of the sensitizing potential of chemicals by in vitro analysis of dendritic cell activation and skin penetration. , 2004, The Journal of investigative dermatology.

[34]  B. De Wever,et al.  Analysis of interleukin-1alpha (IL-1alpha) and interleukin-8 (IL-8) expression and release in in vitro reconstructed human epidermis for the prediction of in vivo skin irritation and/or sensitization. , 2003, Toxicology in vitro : an international journal published in association with BIBRA.

[35]  G Frank Gerberick,et al.  Hapten–protein binding: from theory to practical application in the in vitro prediction of skin sensitization , 2005, Contact dermatitis.

[36]  H. Lou,et al.  Induction of AKR1C2 by Phase II Inducers: Identification of a Distal Consensus Antioxidant Response Element Regulated by NRF2 , 2006, Molecular Pharmacology.